Clinical trials
Completed Observational trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
539 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 2 |
| 2002 | 2 |
| 2003 | 10 |
| 2004 | 12 |
| 2005 | 16 |
| 2006 | 16 |
| 2007 | 21 |
| 2008 | 19 |
| 2009 | 31 |
| 2010 | 24 |
| 2011 | 24 |
| 2012 | 34 |
| 2013 | 24 |
| 2014 | 45 |
| 2015 | 27 |
| 2016 | 30 |
| 2017 | 34 |
| 2018 | 27 |
| 2019 | 35 |
| 2020 | 25 |
| 2021 | 24 |
| 2022 | 22 |
| 2023 | 6 |
| 2024 | 8 |
| 2025 | 6 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 539 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Children's Oncology Group | 25 |
| AstraZeneca | 15 |
| Abbott Medical Devices | 12 |
| AbbVie | 9 |
| Bristol-Myers Squibb | 9 |
| Novartis Pharmaceuticals | 9 |
| Novo Nordisk A/S | 9 |
| The Alfred | 9 |
| Australian and New Zealand Intensive Care Research Centre | 8 |
| Bayside Health | 8 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Failure | 21 |
| Multiple Sclerosis | 13 |
| Critical Illness | 12 |
| Arthritis, Rheumatoid | 11 |
| Breast Neoplasms | 11 |
| Diabetes Mellitus, Type 2 | 11 |
| HIV Infections | 10 |
| Obesity | 10 |
| Atrial Fibrillation | 9 |
| Hepatitis C | 9 |
Trials
Showing 1 to 25 of 539. Each trial links to its page on Pharma Observatory.
439 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.